Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electrophysiological Markers of Cortical Excitability to Predict Response to Treatment with Anti-seizure Medication - the ECORTA Study

NCT05551403 is registered in ClinicalTrials.gov with Stichting Epilepsie Instellingen Nederland as lead sponsor.

NCT NCT05551403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05551403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electrophysiological Markers of Cortical Excitability to Predict Response to Treatment with Anti-seizure Medication - the ECORTA Study
Lead sponsor
Stichting Epilepsie Instellingen Nederland
Phase
Not applicable
Overall status
Completed
Start date
March 16, 2022
Completion date
February 14, 2025
Enrollment
28 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy